Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ironwood Pharmaceuti (IRWD)

Ironwood Pharmaceuti (IRWD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,171,977
  • Shares Outstanding, K 161,967
  • Annual Sales, $ 389,520 K
  • Annual Income, $ 106,180 K
  • 60-Month Beta 1.39
  • Price/Sales 5.45
  • Price/Cash Flow 16.03
  • Price/Book 19.21
Trade IRWD with:

Options Overview

Details
  • Implied Volatility 60.64%
  • Historical Volatility 25.29%
  • IV Percentile 37%
  • IV Rank 34.55%
  • IV High 116.07% on 04/12/21
  • IV Low 31.37% on 06/21/21
  • Put/Call Vol Ratio 0.05
  • Today's Volume 584
  • Volume Avg (30-Day) 646
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 26,032
  • Open Int (30-Day) 24,794

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.23
  • Number of Estimates 4
  • High Estimate 0.25
  • Low Estimate 0.20
  • Prior Year 0.16
  • Growth Rate Est. (year over year) +43.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.96 +10.03%
on 07/08/21
13.65 -3.59%
on 07/29/21
+0.44 (+3.46%)
since 06/29/21
3-Month
10.30 +27.83%
on 05/06/21
13.65 -3.59%
on 07/29/21
+1.90 (+16.87%)
since 04/29/21
52-Week
8.63 +52.49%
on 09/29/20
13.65 -3.59%
on 07/29/21
+4.02 (+43.98%)
since 07/29/20

Most Recent Stories

More News
Abiomed (ABMD) to Report Q1 Earnings: What's in the Cards?

Continued strength in Abiomed's (ABMD) Impella product line is expected to have driven up Q1 sales.

IRWD : 13.16 (-1.86%)
ILMN : 491.63 (-0.12%)
HSIC : 80.22 (+0.98%)
ABMD : 324.81 (+0.31%)
Ironwood (IRWD) Hits 52-Week High, Can the Run Continue?

Ironwood (IRWD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

IRWD : 13.16 (-1.86%)
VRTX : 200.38 (-0.92%)
REPH : 1.8400 (+2.22%)
SPRCY : 5.4500 (-3.54%)
What's in Store for Perrigo (PRGO) This Earnings Season?

Perrigo's (PRGO) new products as well as products added through acquisitions are expected to have aided the company's top line in the soon-to-be-reported quarter.

IRWD : 13.16 (-1.86%)
PRGO : 47.89 (+1.16%)
NKTR : 16.06 (-1.17%)
PETQ : 35.52 (-1.00%)
Incyte (INCY) to Post Q2 Earnings: Will Jakafi Sales Disappoint?

Investors are likely to focus on pipeline updates besides top and bottom-line numbers when Incyte (INCY) reports second-quarter 2021 results.

NVS : 92.19 (+0.33%)
IRWD : 13.16 (-1.86%)
INCY : 77.40 (-0.78%)
ABBV : 118.87 (+0.27%)
Gilead (GILD) to Report Q2 Earnings: What's in the Cards?

Investors will focus on the HIV franchise's performance and Veklury sales when Gilead (GILD) reports second-quarter 2021 results.

IRWD : 13.16 (-1.86%)
PFE : 42.79 (-1.52%)
GILD : 69.83 (-0.33%)
ABBV : 118.87 (+0.27%)
Is a Beat in Store for Bristol-Myers (BMY) in Q2 Earnings?

Investors will focus on regular top and bottom-line numbers along with key pipeline updates when Bristol-Myers (BMY) reports second-quarter 2021 results.

IRWD : 13.16 (-1.86%)
BMY : 68.15 (-0.84%)
PFE : 42.79 (-1.52%)
BLUE : 25.66 (-1.31%)
Vaxart (VXRT) to Report Q2 Earnings: What's in the Cards?

On Vaxart's (VXRT) second-quarter earnings call, investors are set to mainly focus on updates on the company's progress with oral vaccine candidates for COVID-19 and Norovirus.

IRWD : 13.16 (-1.86%)
PFE : 42.79 (-1.52%)
CTLT : 119.32 (+2.41%)
VXRT : 7.80 (-4.99%)
Tilray (TLRY) to Report Q4 Earnings: What's in the Cards?

Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports fiscal fourth-quarter results.

IRWD : 13.16 (-1.86%)
ABBV : 118.87 (+0.27%)
EXAS : 111.91 (-3.58%)
TLRY : 15.42 (-3.69%)
Ironwood Pharmaceuticals to Host Second Quarter 2021 Investor Update Call

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its second quarter 2021 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 5, 2021. Individuals...

IRWD : 13.16 (-1.86%)
Ardelyx (ARDX) Tumbles Following Deficiencies in Tenapanor NDA

The FDA notes deficiencies in the NDA seeking approval for Ardelyx's (ARDX) lead pipeline candidate, tenapanor, as a potential treatment for hyperphosphatemia.

IRWD : 13.16 (-1.86%)
ABBV : 118.87 (+0.27%)
ARDX : 1.7100 (-1.16%)
BHC : 29.59 (+0.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome...

See More

Key Turning Points

3rd Resistance Point 14.07
2nd Resistance Point 13.86
1st Resistance Point 13.51
Last Price 13.16
1st Support Level 12.95
2nd Support Level 12.74
3rd Support Level 12.39

See More

52-Week High 13.65
Last Price 13.16
Fibonacci 61.8% 11.73
Fibonacci 50% 11.14
Fibonacci 38.2% 10.55
52-Week Low 8.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar